Vast white greenhouses sit high up on the slopes of Lesotho's Marakabei town, hidden from view.
It's not fruit or vegetables, however, growing under the 18 plastic covers, but thousands of cannabis plants.
The cannabis is grown legally by the Lesotho-based company Medigrow and is regulated by the government.
"We have three rows that contain 1,200 plants each. That's 3,600 plants across the whole structure," said Medigrow's head of production Albert Theron, gazing proudly over the crop.
In 2017, the tiny landlocked kingdom of 2.1 million people decided to tap into the booming medical marijuana industry, becoming the first country in Africa to allow the cultivation of cannabis for medicinal purposes.
In order to meet legal standards, most traces of tetrahydrocannabinol (THC) -- the main psychoactive constituent responsible for marijuana's intoxicating effects -- are removed from the seeds.
The remaining medical version is primarily made of the non-psychoactive substance, cannabidiol (CBD), and can only be 0.03 percent THC.
Medigrow has invested $19.3 million (17.4 million euros) in cannabis-growing facilities around the country's capital, Maseru.
A heliport is also being built to ensure the cannabis -- commonly referred to as "green gold" -- is shipped safely and swiftly, said head of operations Relebohile Liphoto.
The investment is spurred by the industry's positive outlook.
The global market for medical cannabis is currently estimated at $150 billion (135 billion euros) and could reach $272 billion in 2028, according to Barclays Bank.
"At the moment we have almost 2,000 kilos (4,400 pounds) of biomass and we are going to produce more than 1,000 litres (260 gallons) of CBD oil," said Liphoto.
"Depending on the market, we can sell cannabis oil at between $6,000 and $21,000 per litre."
"So far we have around 10 businesses operating on the territory."
"Unfortunately they did not."
"The Koena (people) are believed to have settled in Lesotho around 1550 by buying land from San groups in exchange for marijuana."
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
